A recent study suggests that people who come off new weight-loss injections like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who halt traditional lifestyle regimens.
Research printed in a prominent health publication points out that while overweight people can lose substantial amounts of their body weight while using the jabs, the weight returns at an estimated rate of nearly a kilo each month after stopping.
"Users buying such medications must be informed of the potential of rapid weight regain when the treatment ends," stated researcher Dr. Susan Jebb.
Such speed of recovery implies a reversion to pre-treatment weight within about one and a half years.
Analyzing Approaches
The study, which looked at dozens of trials involving thousands of participants, contrasted the results of GLP-1 agonists with older methods.
Scientists note that individuals who lose weight through lifestyle changes alone typically see a less rapid creep back—around 100 grams monthly—once they finish.
Understanding the Quick Rebound
Doctors believe the way of the jabs accounts for the heightened rebound.
These medications copy a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the body to produce less of its own natural GLP-1, and could lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' leads to appetite is uncontrolled, making overeating much more probable."
An Ongoing Issue?
The NHS suggest the jabs for individuals with obesity-related health risks, accompanied by recommended lifestyle changes.
Professionals argue that, considering the high risk of relapse, the treatment is often long-term.
This perspective is echoed by pharmaceutical companies, who note that the results "underscore the chronic character of excess weight," similar to managing diseases like diabetes.
User Testimonies
Individuals who have come off the medication describe a sudden resurgence of cravings.
"I experienced a switch activating and you're instantly extremely hungry," described a patient.
This challenge is worsened if patients have not adopted sustainable dietary or behavioural changes during treatment.
Widespread Adoption
Figures indicate that millions of people in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Use is greater among females compared to males.
- The middle-aged demographic shows the highest usage rates.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, experts emphasize that while GLP-1 drugs are potent tools for weight loss, they are not a magic cure and lasting health benefits likely depends on combined behavioural changes.
